Old Web
English
Sign In
Acemap
>
authorDetail
>
Ya-Chi Chen
Ya-Chi Chen
Genentech
Breast cancer
Medicine
Estrogen receptor
Palbociclib
HER2 negative
2
Papers
8
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer.
2021
Expert Opinion on Investigational Drugs
Ya-Chi Chen
Jiajie Yu
Ciara Metcalfe
Tom De Bruyn
Thomas Gelzleichter
Vikram Malhi
Pablo D Perez-Moreno
Xiaojing Wang
Show All
Source
Cite
Save
Citations (0)
A phase Ib study to evaluate the oral selective estrogen receptor degrader GDC-9545 alone or combined with palbociclib in metastatic ER-positive HER2-negative breast cancer.
2020
Journal of Clinical Oncology
Elgene Lim
Komal Jhaveri
José Alejandro Pérez Fidalgo
Meritxell Bellet
Valentina Boni
Jose P. Garcia
Laura G. Estévez
Aditya Bardia
Nicholas C. Turner
Rafael Villanueva
Sara Lopez-Tarruella Cobo
Seock-Ah Im
Sung-Bae Kim
Mary Gates
Sharareh Monemi
Ya-Chi Chen
Heather M. Moore
Sherene Loi
Joohyuk Sohn
Show All
Source
Cite
Save
Citations (8)
1